Congress Wealth Management LLC DE Buys New Stake in British American Tobacco p.l.c. (NYSE:BTI)
Congress Wealth Management LLC DE acquired a new stake in shares of British American Tobacco p.l.c. (NYSE:BTI – Free Report) during the fourth quarter, according to its most recent disclosure with the ...
BioXcel Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
Full Year 2024 Results Key Financial Results Net loss: US$59.6m (loss narrowed ...
BioXcel Therapeutics price target lowered to $1 from $4 at BofA
BofA analyst Alec Stranahan lowered the firm’s price target on BioXcel Therapeutics (BTAI) to $1 from $4 and keeps an Underperform rating on ...
BioXcel Therapeutics reports Q4 EPS ($3.57), consensus ($5.14)
Reports Q4 revenue $366k, consensus $718.26k. “We believe that our SERENITY program presents an exciting opportunity to address a substantial ...
BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2024
Enrollment exceeds 60% of required number of patients in SERENITY At-Home pivotal Phase 3 safety trial evaluating 200 ...
bdnews24.com5d
Chattogram City Corporation using BTI to kill mosquitoes
The Chattogram City Corporation (CCC) has begun an experimental deployment of Bacillus thuringiensis israelensis (BTI), a ...
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Receives $42.60 Consensus Target Price from Brokerages
BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the ...